Skip to main content
. 2017 Feb 8;9(1):36–43. doi: 10.5114/jcb.2017.65839

Table 1.

Patient and tumor characteristics

Characteristics Total (%) 70-74 years (%) > 74 years (%) p value
Gender 0.550
 Male 103 (53.9) 60 (52.2) 43 (56.5)
 Female 88 (46.1) 55 (47.8) 33 (43.5)
KPS 0.001
 ≥ 80 90 (47.1) 65 (56.5) 25 (32.9)
 70 101 (52.9) 50 (43.5) 51 (67.1)
The length 0.029
 ≤ 5.0 cm 99 (51.8) 67 (58.3) 32 (42.1)
 > 5.0 cm 92 (48.2) 48 (41.7) 44 (57.9)
Tumor location 0.079
 Upper 51 (26.7) 37 (32.2) 14 (18.4)
 Middle 123 (64.4) 67 (58.3) 56 (73.7)
 Lower 6 (7.9) 11 (9.5) 6 (7.9)
T stage 0.098
 T2 40 (20.9) 29 (25.2) 11 (14.5)
 T3 66 (34.6) 34 (29.6) 32 (42.1)
 T4 85 (44.5) 52 (45.2) 33 (43.4)
N stage 0.279
 N0 109 (57.1) 62 (53.9) 47 (61.8)
 N1 82 (42.9) 53 (46.1) 29 (38.2)
6th AJCC stage 0.810
 IIa 72 (30.7) 43 (37.4) 29 (38.2)
 IIb 10 (5.0) 7 (6.1) 3 (3.9)
 III 109 (64.3) 65 (56.5) 44 (57.9)
RT dose 0.047
 ≤ 66 Gy 167 (87.4) 105 (91.3) 62 (81.6)
 > 66 Gy 24 (12.6) 10 (8.7) 14 (18.4)

RT – radiotherapy alone, OS – overall survival rate, LCR – local control rate